Electroceuticals in Neurologic and Psychiatric Disorders

Faculty

David Paydarfar, MD
Professor and Chair, Department of Neurology
Dell Medical School, The University of Texas at Austin Austin, TX
David Paydarfar, MD
Professor and Chair, Department of Neurology

David Paydarfar is professor and the inaugural chair of the Department of Neurology at Dell Medical School. He previously served as professor and executive vice chair of the Department of Neurology at the University of Massachusetts Medical School, and as an associate faculty member of the Wyss Institute for Biologically Inspired Engineering at Harvard University. Paydarfar received a B.S. in physics (summa cum laude) from Duke University and an MD degree from The University of North Carolina at Chapel Hill. He completed his residency training in neurology at Massachusetts General Hospital and Harvard Medical School. He practices general neurology and is a fellow of the American Neurological Association and an investigator of the Clayton Foundation for Research.

Paydarfar’s clinical research program seeks to develop novel biosensors, signal-processing algorithms and user interfaces that will enable clinicians and researchers to track and predict the health of individual patients as well as entire populations. This approach will extend beyond current reactive alarm systems, enabling doctors to forecast and avert adverse disease trajectories and to test the impact of such a strategy on health outcomes. This engineering and informatics platform should provide unprecedented opportunities to conduct fieldwork on human physiology and pathophysiology.

Paydarfar’s basic research program seeks to understand mechanisms underlying disease states associated with abnormal behavior of neural oscillators such as apnea, circadian dysrhythmias and epilepsy, as well as the coordination of pacemakers with other physiological and behavioral functions. His research is funded by the National Institutes of Health, the National Science Foundation and the Clayton Foundation for Research.

Statement of Need

This video is a replay of a plenary session from the 12th Annual Chair Summit Master Class for Neuroscience Professional Development held in Las Vegas, NV from February 27 – 29, 2020.

Learning Objectives

At the end of this CME/CE activity, participants should be able to identify the role of electroceutical treatment in neurologic and psychiatric disorders.

Financial Support

This activity is supported by CME Outfitters.

Target Audience

Physicians, physician assistants, nurse practitioners, nurses, and other healthcare professionals with an interest in psychiatry, neurology, and the neurosciences.

Credit Information

Physicians (ACCME) 1.0

CME Outfitters, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABPN MOC

ABPN Diplomates may select any CME activity relevant to their practice to count towards ABPN MOC requirements.

Note to Nurse Practitioners

Nurse Practitioners can apply for AMA PRA Category 1 Credit through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit  from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.


Dr. Paydarfar reports that he receives grant and research support from Clayton Foundation; Merck & Co., Inc.; National Institutes of Health (NIH)); National Science Foundation (NSF); and Texas Alzheimer’s Research and Care Consortium. He serves on the advisory committee for Prapela, Inc.


Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.

  • Howard Bliwise, MD (peer reviewer) has no disclosures to report.
  • Mae Ochoa, RPh (peer reviewer) has no disclosures to report.
  • Evan Luberger (planning committee) has no disclosures to report.
  • Jan Perez (planning committee) has no disclosures to report.
  • Sharon Tordoff (planning committee) has no disclosures to report.

 

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Additional Formats

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

 

CHV-098-091120-00

Electroceuticals in Neurologic and Psychiatric Disorders
Event Date: 09/11/2020